Skip to content

Clinical trials

Completed Atherosclerosis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Status: Completed Country / region: Canada Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20034
20054
20061
20084
20093
20103
20112
20123
20131
20143
20156
20164
20172
20183
20193
20203
20224

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Boston Scientific Corporation3
Laval University3
Novartis Pharmaceuticals3
Amgen2
Dr. Amer Johri2
Esperion Therapeutics, Inc.2
Ionis Pharmaceuticals, Inc.2
Ottawa Heart Institute Research Corporation2
University of Alberta2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis56
Cardiovascular Diseases14
Coronary Artery Disease9
Coronary Disease7
Diabetes Mellitus7
Heart Diseases6
Myocardial Infarction6
Stroke5
Acute Coronary Syndrome4
Hypercholesterolemia4

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.